| Diana Lorena Ceron, LPC | |
|
147 Columbian Turnpike, Suit 307, Florham Park, NJ 07307 | |
| (201) 284-8040 | |
| Not Available |
| Full Name | Diana Lorena Ceron |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 147 Columbian Turnpike, Florham Park, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033552872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 37PC00473200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diana Lorena Ceron, LPC 256 Liberty Ave, Jersey City, NJ 07307-4414 Ph: (201) 284-8040 | Diana Lorena Ceron, LPC 147 Columbian Turnpike, Suit 307, Florham Park, NJ 07307 Ph: (201) 284-8040 |
News Archive
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
Conceptus, Inc., developer of the Essure procedure, the first proven non-incisional permanent birth control method available, today announced that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has updated its guidance on hysteroscopic sterilization to support the use of the Essure permanent birth control procedure.
Agfa HealthCare announces today that it is releasing a new version of its Enterprise Imaging platform. Customer-driven enhancements include academic, multi-site, radiology and additional specialty workflows for medical imaging.
Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults.
A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai.
› Verified 2 days ago
Daphne Berkovits, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 256 Columbia Tpke Ste 105, Florham Park, NJ 07932 Phone: 973-765-9050 | |
Ben K Beitin, PH.D. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 135 Columbia Tpke, Suite 303, Florham Park, NJ 07932 Phone: 973-229-3570 | |
Mailen Ayelen Palacios, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 135 Columbia Tpke Ste 303, Florham Park, NJ 07932 Phone: 973-229-3570 |